Eugenia Broude
Benjamin D. Brooks
Vice President of Research & Development
  • : 801 885-4073   
    : 844-642-7635

Department of Research & Development
Carterra Inc.


(if applicable)
Completion Date
University of Wyoming, Laramie, WY B.S. 08/1999 Mathematics
University of Wyoming, Laramie, WY MBA 08/2002 Business Administration
University of Wyoming, Laramie, WY PhD 12/2008 Molecular Biology
Scripps Research Institute, San Diego, CA Visit.Grad Student 12/2007 Immunology
University of Utah, Salt Lake City, UT Postdoc 10/2009 Pharmaceutics



Dr. Brooks has been involved in management of several tech start-up ventures developing bone void filler, ultrasensitive detection of prion proteins, and computer programming. He received his Ph.D. in Molecular Biology and MBA from the University of Wyoming, with one year as a visiting researcher at The Scripps Research Institute where he studied ultrasensitive detection of proteins using microarrays and other ultrasensitive immunoassays. Dr. Brooks completed his postdoctoral fellowship from the University of Utah in Pharmaceutics where he managed projects including effects of nanoparticles on coagulation cascade, protein microarrays, and drug releasing polymers for orthopedic applications. 


Research Interest

1. Immunoassays
2. Nanoparticles
3. Cell Printing
4. Antibiotic Release

Professional Activities:


2012 – Present VP, Research and Development, Wasatch Microfluidics, Inc., Salt Lake City, UT
2009 – 2012 Postdoctoral Fellow, Dept. of Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT
2006 – 2008 Visiting Graduate Student, The Scripps Research Institute, Sand Diego, CA
2000 – 2003 Instructor, Dept. of Computer Science and Business Technology, Casper College, Casper, WY


2003 Gamma Sigma Delta Honor Society of Agriculture
1995       Mortar Board and Golden Key Honor Societies



  1. “The Submerged Printing of Cells onto a Functionalized Surface Using a Continuous Flow Microspotter.” Journal of Visualized Experiments. [2014, 86: e51273-e51273]. SN Davidoff, BD Brooks.
  2. “Comparison of Submerged and Unsubmerged Printing of Ovarian Cancer Cells.” Biomedical sciences instrumentation. [2015, 51: 24-30]. SN Davidoff, D Au, S Smith, AE Brooks, BD Brooks.
  3. “Maximizing Fibroblast Adhesion on Protein-Coated Surfaces Using Microfluidic Cell Printing” Integrative Biology. [In submission]. SN Davidoff, D Au, BG Gale, AE Brooks, BD Brooks.
  4. “Surface Plasmon Resonance Arrays for Antibody Characterization.”  Label-free biosensor methods in drug discovery.  Label-Free Biosensor Methods in Drug Discovery (Book Chapter in Springer Protocols Book Series.)  [2015:35-76]. SN Davidoff, NT Ditto, AE Brooks, JW Eckman, BD Brooks.
  5. “An overview of Epitope Binning and its importance to Biological Drug Discovery.”  Expert Opinion in Drug Discovery.  [Invited Paper Submission, In Review].
  6. “The Importance of Epitope Binning for Biological Drug Discovery.” Current Drug Discovery Technologies.[2014/06, 11(2):109]. BD Brooks.
  7. “High-throughput epitope binning of therapeutic monoclonal antibodies: why you need to bin the fridge!” Drug Discovery Today. [2014/08, 19(8): 1040–1044]  BD Brooks, AR Miles,YN Abdiche.
  8. Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model.”  Biomaterials. [2014]. AI Astashkina, CF Jones, G Thiagarajan, K Kurtzeborn, H Ghandehari, BD Brooks, DW Grainger.
  9. “Cationic PAMAM dendrimers aggressively initiateblood clot formation.” ACS-Nano.[2012, 6 (11): 9900–9910]. CF Jones,AS Weyrich, H Ghandahari,BD Brooks, AS Weyrich, DW Grainger, et al.
  10. "Cationic dendritic nanoparticles disrupt key platelet functions." Molecular Pharmaceutics. [2012/06 4;9(6):1599-611].  CF Jones, R Campbell, BD Brooks, H Ghandahari, AS Weyrich, DW Grainger.
  11. “A Critical Comparison of Protein Microarray Fabrication Technologies.” Analyst. [2014, 139:303-1326]. V Romanov, SN Davidoff, AR Miles, DW Grainger, BK Gale, BD Brooks.